• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 80

ARASCO (arachidonic acid-rich single-cell oil)

Intended Use: Provide ARASCO (as a source of arachidonic acid) in term infant formula, at a maximum level of 1.88 percent of total dietary fat when used in combination with DHASCO (docosahexaenoic acid-rich single-cell oil; as a source of docosahexaenoic acid) at a maximum level of 1.25 per cent of the total dietary fat and at a ratio ranging from 1:1 to 1:2 (DHASCO:ARASCO)
Basis: Scientific procedures
Notifier: Mead Johnson Nutritionals
Notifier Address: 2400 West Lloyd Expressway, Evansville, IN 47721
Date of filing: Aug 6, 2001
GRAS Notice (releasable information): GRN 80 part 1 (in PDF) (5.7 MB)
  Part 2: GRN 80 part 2 with amendments (in PDF) (6.2 MB)
Date of closure: Dec 11, 2001
FDA's Letter: FDA has no questions